A Phase I, single— and repeated—dose study of TAS—205 in patients with Duchenne muscular dystrophy

Eri Takeshita

Presentation information

Oral Presentation

Muscular disease

[O13] Muscular disease

Thu. May 31, 2018 1:30 PM - 2:40 PM Room 9 (1F 104)

Chair: Yasuhiro Takeshima(Department of Pediatrics, Hyogo College of Medicine), YUKA ISHIKAWA(Department of Pediatrics, National Organization Yakumo Hospital, Hokkaido, Japan)

[O-070] A Phase I, single— and repeated—dose study of TAS—205 in patients with Duchenne muscular dystrophy

Eri Takeshita¹, HIROFUMI KOMAKI^1,2, YUKO MOTOHASHI¹, AKIHIKO ISHIYAMA¹, KAZUHISA MIYOSHI³, IKUO YAMAMIYA³, NOBUKO YAMADA³, NAOKO MINAMI³ (1.Department of Child Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 2.Department of Clinical Research Promotion, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan, 3.Taiho Pharmaceutical Co. Ltd.)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.